Benson Fayehun is a dynamic leader with over 20 years of extensive experience in the pharmaceutical industry, currently serving as the Board Member, President, and Founder of the Relief for Human Suffering Foundation (R4HSF). Since establishing R4HSF in 2021, Benson has been at the forefront...
Benson Fayehun is a dynamic leader with over 20 years of extensive experience in the pharmaceutical industry, currently serving as the Board Member, President, and Founder of the Relief for Human Suffering Foundation (R4HSF). Since establishing R4HSF in 2021, Benson has been at the forefront of driving strategic initiatives aimed at alleviating poverty-related blindness, a cause that resonates deeply with his commitment to social enterprise and community health. Under his leadership, the foundation has rapidly expanded its outreach and impact, leveraging his substantial expertise in general management and operational planning to implement effective programs and partnerships.
Benson’s background in commercial leadership within top global pharmaceutical companies equips him with a unique perspective on market access and payer strategy, essential for navigating the complexities of healthcare systems. His experience in launching successful therapies across various therapeutic areas, including oncology, hematology, and rare diseases, informs R4HSF's approach to addressing health disparities. He is adept at fostering cross-company collaboration, which has been instrumental in building alliances with stakeholders and enhancing the foundation's capacity to deliver on its mission.
In addition to his operational acumen, Benson is passionate about leading positive change and promoting diversity, equity, and inclusion within the healthcare landscape. His commitment to board governance and change management ensures that R4HSF not only responds to immediate needs but also builds sustainable solutions for the future. As he continues to champion the cause of those affected by preventable blindness, Benson Fayehun exemplifies the intersection of commercial expertise and humanitarian dedication, driving meaningful change in the lives of many.
